Since our founding in 1997, we have deployed over $2 billion of equity capital on behalf of our funds and co-investors in over 50 investments across Asia. Below is a selected list of previous and current investments.
Asurion Asia Pacific was a joint venture between Olympus Capital Asia and Asurion Corporation (“Asurion”), a global provider of consumer technology protection services. The joint venture was formed to introduce Asurion’s business model in Asia. Today Asurion offers technical support to help customers derive optimum benefit from the usage of electronics, mobile security to help ensure content privacy, and rapid replacement of lost, stolen, damaged or malfunctioning devices.
Arysta LifeScience Corporation (“Arysta”), headquartered in Japan, is the world’s largest privately held agrochemical company. Arysta specializes in the development, registration, formulation, marketing and distribution of conventional crop protection products such as herbicides, insecticides, fungicides and growth regulators, which account for approximately 90% of the Company’s revenues. Arysta also develops and distributes life sciences products targeting animal health, human health, and plant nutrition. Arysta has an extensive product portfolio comprising more than 150 products in over 125 countries around the world.
- Financial & Business Services
- Japan, Regional/Cross-Border, SE Asia
Asia Project Holdings was a joint venture with Fuji Bank (now Mizuho Bank) of Japan to invest in a portfolio of Southeast Asian project finance loans. The loans were senior debt securities primarily in natural resources, petrochemical and other industrial projects, with world-class multinational sponsors and strong risk-mitigating structures.
Aster DM Healthcare (“Aster” or the “Company”) is an Indian company that is a leading healthcare services provider in the Gulf Cooperation Council (“GCC”) countries and India. The Company runs clinics, pharmacies and hospitals in several GCC countries (the United Arab Emirates, Saudi Arabia, Oman and Qatar) and owns secondary and tertiary care hospitals in India. Aster currently has 2,300 beds under operation and plans to commission an additional 1,500 beds in the next three years, predominantly in India.
Clearwater Capital Partners (“Clearwater”), founded by three principals with extensive experience in Asian debt markets, is an investment management company focusing on Asian distressed debt securities. Olympus sponsored the formation of Clearwater and its first investment vehicle. Olympus Capital Asia was the largest investor in Clearwater’s first fund and owned a minority stake in the management company. Olympus subsequently invested into other investment vehicles managed by Clearwater.